Trump’s tariffs could leave the pharma industry scramblingnews2025-04-02T20:48:38+00:00April 2nd, 2025|Endpoints News|
New CDMO emerges, acquires cell and gene manufacturer Landmark Bionews2025-04-02T09:00:38+00:00April 2nd, 2025|Endpoints News|
Milestone’s shares dive after FDA again rejects drug for abnormal heart rhythmnews2025-03-28T14:51:44+00:00March 28th, 2025|Endpoints News|
New pharma tariffs could put generic drugmakers under pressurenews2025-03-27T17:10:05+00:00March 27th, 2025|Endpoints News|
Chiesi pours €430 into new Italy site; Bharat’s first CGT site in Indianews2025-03-27T15:10:28+00:00March 27th, 2025|Endpoints News|
WuXi Biologics’ licensing deals help offset Biosecure threat in the USnews2025-03-25T15:11:03+00:00March 25th, 2025|Endpoints News|
Trump pharma tariffs: Details on impact and timingnews2025-03-24T19:59:47+00:00March 24th, 2025|Endpoints News|
Liver cancer drug combo gets its second FDA rejectionnews2025-03-21T22:28:58+00:00March 21st, 2025|Endpoints News|
AstraZeneca puts $2.5B toward first vaccine factory and second R&D site in Chinanews2025-03-21T15:24:18+00:00March 21st, 2025|Endpoints News|
Johnson & Johnson earmarks $55B to boost US capacity news2025-03-21T11:16:37+00:00March 21st, 2025|Endpoints News|
